MyFinsight
Home
Blog
About
Contact
Download
Download image
Stock-based compensation
$87,410K
Proceeds from stock
options exercised, net
$19,205K
Accounts payable,
accrued expenses, and...
$82,777K
Depreciation and
amortization
$7,460K
Foreign currency
remeasurement loss
-$3,586K
Amortization of debt discount
and deferred...
$2,570K
Net cash provided by
(used in) operating...
$33,145K
Effect of exchange rate
changes on cash, cash...
$13,277K
Net cash provided by
financing activities
$610K
Canceled cashflow
$150,658K
Canceled cashflow
$18,595K
Net increase
(decrease) in cash, cash...
$600K
Canceled cashflow
$46,432K
Inventories
$111,483K
Net loss
-$27,110K
Accounts receivable
$5,860K
Other non-current
assets and liabilities
-$3,685K
Prepaid expenses and
other current assets
$1,382K
Asset impairment
charges and other...
-$1,138K
Sale and redemption
of marketable...
$51,269K
Withholding taxes paid on
vested restricted...
$18,323K
Payment of finance
leases
$272K
Net cash (used in)
provided by investing...
-$46,432K
Canceled cashflow
$51,269K
Purchases of marketable
securities
$94,405K
Capital expenditures
$3,296K
Back
Back
Cash Flow
source: myfinsight.com
logosdsadsad-svg
AMICUS THERAPEUTICS, INC. (FOLD)
logosdsadsad-svg
AMICUS THERAPEUTICS, INC. (FOLD)